A Study on the Effect of Nipocalimab on Vaccine Responses in Healthy Participants
Clinical trial NCT05827874 · COMPLETED
Trial details
- NCT number
- NCT05827874
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-12
- Primary completion
- 2023-10-04
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.